Upgrade to SI Premium - Free Trial

Anavex Life Sciences (AVXL) Offers Statistically Significant Preclinical ANAVEX 3-71 Data in Alzheimer’s Disease

March 14, 2016 7:03 AM
Anavex Life Sciences Corp. (Nasdaq: AVXL) announced positive preclinical data on sigma-1 agonist ANAVEX 3-71 (formerly AF710B). The results ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Management Comments

Next Articles